Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/26 18:25 | 5/22/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Venker Eric | O | P,Immuno | 3 | S.d | -17,620 | 29.37 | 0 | -600 | 1,648 | D | ||||||||||||||||
4/20/26 18:27 | 4/16/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Gline Matthew | DO | CEO | 1 | S | -8,450 | 29.16 | 0 | -290 | 16,736 | D | ||||||||||||||||
4/10/26 18:00 | 4/8/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Humes Jennifer | O | Chief Ac | 1 | S | -384 | 28.37 | 0 | -14 | 84 | D | ||||||||||||||||
3/30/26 21:01 | 3/26/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Fitzgerald Meghan | D | 1 | S.d | -1,922 | 27.45 | 0 | -70 | 43 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |